Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Sunesis
shares soar on leukemia drug trial results 2:45 PM 12/8/2009
Forbes
Sunesis Pharmaceuticals Inc's drug candidate voreloxin improved survival
for patients with treatment-resistant leukemia in clinical testing.
...
US
FDA questions studies of Gilead fibrosis drug 12:13 PM 12/8/2009
Reuters
The US FDA is concerned about the design and analysis of clinical studies
intended to support the effectiveness of Gilead Sciences Inc's experimental aztreonam for treating respiratory
symptoms and pulmonary function in some cystic fibrosis patients.
...
Drugmakers
back in spotlight as US reform amps up 10:30 AM 12/8/2009
Reuters
Democrats had largely shielded the $315 billion industry until Wall Street and
consumer groups reported that drug prices have risen nearly 10 percent this year.
...
Geron:
interim data shows cancer vaccine meets goals 7:38 AM 12/8/2009
Reuters
Geron Corp said interim data from a mid-stage trial showed its cancer
vaccine GRNVAC1 met goals of safety and tolerability. GRNVAC1 targets telomerase is an enzyme which found in
many malignant tumors.
...
Tranzyme
to research drugs for Bristol-Myers 6:32 AM 12/8/2009
MSN Money
Tranzyme Pharma will find and study potential new drugs for Bristol-Myers Squibb Co
in a deal worth $16 million over the next two years.
...
Actelion
latest casualty as Roche trims portfolio 5:15 AM 12/8/2009
Reuters
Roche Holding is ending deals with biotechs Actelion to develop autoimmune drug and
Genmab for its experimental cancer drug.
...
Ranbaxy
Sells Stake in Venture to Nippon Chemiphar 3:35 AM 12/8/2009
Bloomberg
Nippon Chemiphar will buy Ranbaxy Laboratories’ 50 percent stake in Nihon
Pharmaceutical Industry Co.
...
US
panel backs Novartis transplant drug 4:43 PM 12/7/2009
Reuters
A US advisory panel recommends approval of Novartis' everolimus drug to prevent
rejection of transplanted kidneys in patients who have undergone kidney transplants.
...
Cephalon
up on news of cancer drug 2:32 PM 12/7/2009
Philadelphia
Inquirer
Analyst says Cephalon Inc's tumor fighter Treanda may reach $1 billion in annual sales or
more than 10 times last year's revenue. Treanda could become a widely used alternative to the chemotherapy
standard.
...
Onyx
Treatment Fights Cancer With Few Side Effects 12:22 PM 12/7/2009
Bloomberg
Onyx Pharmaceuticals Inc’s carfilzomib worked in patients with multiple
myeloma and helped reduce neuropathy.
...
Somaxon
Plunges As FDA Again Says Silenor Can't Be Approved 7:56 AM 12/7/2009
Wall Street Journal
The US FDA has again ruled Somaxon Pharmaceuticals
Inc's proposed insomnia treatment Silenor can't be approved because the company hasn't demonstrated efficacy.
...
Celgene
to buy Gloucester in cancer drug deal 7:13 AM 12/7/2009
Forbes
Celgene Corp will buy privately held Gloucester Pharmaceuticals and its drug Istodax
for treatment of cutaneous T-cell lymphoma for as much $640 million.
...
ChemGenex
Says Drug Rids Leukemia From Blood of 86% of
Patients 12:26 PM 12/5/2009
Bloomberg
ChemGenex Pharmaceuticals Ltd said its experimental leukemia drug Omapro cleared the
disease in 86 percent of patients with chronic myeloid leukemia (CML).
...
Allos
says Idis to supply its cancer drug outside US 10:38 AM 12/4/2009
Reuters
Allos Therapeutics Inc said UK-based Idis agreed to distribute its cancer
drug Folotyn to healthcare providers outside the US on a named patient basis.
...
Experimental
drug is combating hepatitis C in chimps 5:08 AM 12/4/2009
Los Angeles
Times
Preliminary tests suggest that the drug SPC3649 has no toxic side effects and does not allow
development of resistance.
...
<- Day Earlier | Today's News
|
